This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
CARVYKTI® (ciltacabtagene autoleucel)
Medical Information
CARVYKTI – Storage and Stability of CARVYKTI
Last Updated: 04/17/2026
SUMMARY
- Johnson & Johnson does not recommend the use of CARVYKTI in a manner inconsistent with the approved labeling.
- The dating period for CARVYKTI shall be 9 months from the date of manufacture when stored at ≤-120°C. The date of manufacture shall be defined as the date of final formulation of the drug product.1
- For inquiries regarding ordering, order journey, CQUENCE portal assistance, order fulfillment (enrollment, order replacement, or scheduling, order cancellation), cell chain and site certification, or shelf-life considerations please contact the CQUENCE Order Support Team at 1-833-CQORDER (1-833-276-7337).
References
| 1 | Food and Drug Administration (FDA). Biologics License Application (BLA) - February 28, 2022 Approval Letter - CARVYKTI. Accessed: March 27, 2026. Available from: https://www.fda.gov/media/156572/download |